000			02187 a2200613 4500
005			20250517020127.0
264		0	_c20150611
008			201506s 0 0 eng d
022			_a1545-5017
024	7		_a10.1002/pbc.25342 _2doi
040			_aNLM _beng _cNLM
100	1		_aStieglitz, Elliot
245	0	0	_aPhase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group. _h[electronic resource]
260			_bPediatric blood & cancer _cApr 2015
300			_a629-36 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aFarnesyl-Diphosphate Farnesyltransferase _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aIsotretinoin _xadministration & dosage
650	0	4	_aLeukemia, Myelomonocytic, Juvenile _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aQuinolones _xadministration & dosage
650	0	4	_aSurvival Rate
650	0	4	_aVidarabine _xadministration & dosage
700	1		_aWard, Ashley F
700	1		_aGerbing, Robert B
700	1		_aAlonzo, Todd A
700	1		_aArceci, Robert J
700	1		_aLiu, Y Lucy
700	1		_aEmanuel, Peter D
700	1		_aWidemann, Brigitte C
700	1		_aCheng, Jennifer W
700	1		_aJayaprakash, Nalini
700	1		_aBalis, Frank M
700	1		_aCastleberry, Robert P
700	1		_aBunin, Nancy J
700	1		_aLoh, Mignon L
700	1		_aCooper, Todd M
773	0		_tPediatric blood & cancer _gvol. 62 _gno. 4 _gp. 629-36
856	4	0	_uhttps://doi.org/10.1002/pbc.25342 _zAvailable from publisher's website
999			_c24644826 _d24644826